Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Ownership 3.50%
Citadel Advisors Llc ownership in 9IP1 / Rocket Pharmaceuticals, Inc.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (9IP1) in the form of stock options. The firm currently holds call options representing 64,900 of underlying shares valued at $232,342 USD and put options representing 67,300 of underlying shares valued at $240,934 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2018-02-14 2018-02-14 13G/A 3.50 -47.76
2017-02-15 2017-02-15 13G/A 6.70 0.00
2017-02-14 2017-02-14 13G/A 6.70 3.08
2016-08-29 2016-08-29 13G 6.50

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:9IP1 / Rocket Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -1,299,991 -100.00 0 -100.00
2026-02-17 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,299,991 -370,936 -22.20 4,563 -16.25 0.0007
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,670,927 1,514,877 970.76 5,447 1,325.92 0.0008
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 156,050 -1,352,954 -89.66 382 -96.20 0.0001
2025-05-15 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,509,004 -2,613,820 -63.40 10,065 -80.58 0.0019
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 4,122,824 1,974,731 91.93 51,824 30.62 0.0090
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 2,148,093 -669,976 -23.77 39,675 -34.61 0.0077
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 2,818,069 348,256 14.10 60,673 -8.81 0.0123
2024-05-15 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 2,469,813 12,252 0.50 66,537 -9.66 0.0128
2024-02-14 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 2,457,561 -220,940 -8.25 73,653 34.20 0.0147
2023-11-14 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 2,678,501 90,393 3.49 54,882 6.72 0.0118
2023-08-14 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 2,588,108 -70,841 -2.66 51,426 12.91 0.0106
2023-05-15 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 2,658,949 56,269 2.16 45,548 -10.58 0.0100
2023-02-14 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 2,602,680 838,759 47.55 50,934 80.92 0.0119
2022-11-14 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,763,921 256,082 16.98 28,152 35.69 0.0064
2022-08-15 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,507,839 -278,416 -15.59 20,748 -26.76 0.0053
2022-05-16 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,786,255 93,289 5.51 28,330 -23.34 0.0058
2022-02-14 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,692,966 393,990 30.33 36,957 -4.81 0.0076
2021-11-15 2021-09-30 13F ROCKET PHARMACEUTICALS Cmn 77313F106 1,298,976 501,297 62.84 38,826 9.90 0.0081
2021-08-16 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 797,679 110,881 16.14 35,330 15.94 0.0079
2021-05-21 2021-03-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 686,798 -632,105 -47.93 30,473 -57.87 0.0075
2021-05-17 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 686,798 -632,105 30,473 0.0075
2021-02-16 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,318,903 207,094 18.63 72,329 184.58 0.0188
2020-11-16 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,111,809 38,105 3.55 25,416 13.10 0.0072
2020-08-14 2020-06-30 13F ROCKET PHARMACEUTICALS Cmn 77313F106 1,073,704 7,735 0.73 22,473 51.13 0.0080
2020-05-15 2020-03-31 13F ROCKET PHARMACEUTICALS Cmn 77313F106 1,065,969 -173,689 -14.01 14,870 -47.30 0.0067
2020-02-14 2019-12-31 13F ROCKET PHARMACEUTICALS Cmn 77313F106 1,239,658 46,457 3.89 28,215 102.97 0.0122
2019-11-14 2019-09-30 13F ROCKET PHARMACEUTICALS Cmn 77313F106 1,193,201 79,033 7.09 13,901 -16.83 0.0066
2019-08-14 2019-06-30 13F ROCKET PHARMACEUTICALS Cmn 77313F106 1,114,168 17,694 1.61 16,713 -13.10 0.0077
2019-05-15 2019-03-31 13F ROCKET PHARMACEUTICALS Cmn 77313F106 1,096,474 16,217 1.50 19,232 20.13 0.0096
2019-02-14 2018-12-31 13F ROCKET PHARMACEUTICALS Cmn 77313F106 1,080,257 322,211 42.51 16,009 -14.22 0.0088
2018-11-13 2018-09-30 13F ROCKET PHARMACEUTICALS Cmn 77313F106 758,046 -71,020 -8.57 18,663 14.67 0.0084
2018-08-14 2018-06-30 13F/A-1 ROCKET PHARMACEUTICALS Cmn 77313F106 829,066 409,564 97.63 16,275 106.90 0.0080
2018-08-10 2018-06-30 13F ROCKET PHARMACEUTICALS Cmn 77313F106 829,066 409,564 16,275
2018-05-14 2018-03-31 13F/A-1 ROCKET PHARMACEUTICALS Cmn 77313F106 419,502 381,837 1,013.77 7,866 7,926.53 0.0043
2018-05-11 2018-03-31 13F ROCKET PHARMACEUTICALS Cmn 77313F106 419,502 7,866
2018-02-09 2017-12-31 13F INOTEK PHARMACEUTICALS Cmn 45780V102 37,665 21,475 132.64 98 237.93 0.0001
2017-11-09 2017-09-30 13F INOTEK PHARMACEUTICALS Cmn 45780V102 16,190 -434 -2.61 29 -9.37 0.0000
2017-08-11 2017-06-30 13F INOTEK PHARMACEUTICALS Cmn 45780V102 16,624 -5,336 -24.30 32 -27.27 0.0000
2017-05-12 2017-03-31 13F INOTEK PHARMACEUTICALS Cmn 45780V102 21,960 -5,317 -19.49 44 -73.49 0.0000
2017-02-10 2016-12-31 13F INOTEK PHARMACEUTICALS Cmn 45780V102 27,277 27,277 61.32 166 31.75 0.0002
2016-11-10 2016-09-30 13F INOTEK PHARMACEUTICALS Cmn 45780V102 0 -16,909 -100.00 0 -100.00
2017-01-31 2016-06-30 13F/A-1 INOTEK PHARMACEUTICALS Cmn 45780V102 16,909 16,909 0.00 126 0.0001
2016-08-12 2016-06-30 13F INOTEK PHARMACEUTICALS Cmn 45780V102 16,909 126
2017-01-31 2015-12-31 13F/A-1 INOTEK PHARMACEUTICALS Cmn 45780V102 0 -32,719 -100.00 0 -100.00
2015-11-16 2015-09-30 13F INOTEK PHARMACEUTICALS Cmn 45780V102 32,719 32,719 308 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ROCKET PHARMACEUTICALS COM Call 64,900 232 n/a n/a n/a
2026-02-17 2025-12-31 13F ROCKET PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM Call 95,200 63.29 310 118.31 n/a n/a n/a
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM Call 58,300 5.81 143 -61.31 n/a n/a n/a
2025-05-15 2025-03-31 13F ROCKET PHARMACEUTICALS COM Call 55,100 98.20 368 5.16 n/a n/a n/a
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM Call 27,800 20.87 349 -17.69 n/a n/a n/a
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM Call 23,000 13.30 425 -2.97 n/a n/a n/a
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM Call 20,300 -57.08 437 -65.70 n/a n/a n/a
2024-05-15 2024-03-31 13F ROCKET PHARMACEUTICALS COM Call 47,300 60.88 1,274 44.61 n/a n/a n/a
2024-02-14 2023-12-31 13F ROCKET PHARMACEUTICALS COM Call 29,400 -67.37 881 -52.28 n/a n/a n/a
2023-11-14 2023-09-30 13F ROCKET PHARMACEUTICALS COM Call 90,100 263.31 1,846 275.20 n/a n/a n/a
2023-08-14 2023-06-30 13F ROCKET PHARMACEUTICALS COM Call 24,800 61.04 493 87.07 n/a n/a n/a
2023-05-15 2023-03-31 13F ROCKET PHARMACEUTICALS COM Call 15,400 -47.97 264 -54.58 n/a n/a n/a
2023-02-14 2022-12-31 13F ROCKET PHARMACEUTICALS COM Call 29,600 -47.70 579 -35.88 n/a n/a n/a
2022-11-14 2022-09-30 13F ROCKET PHARMACEUTICALS COM Call 56,600 201.06 903 248.65 n/a n/a n/a
2022-08-15 2022-06-30 13F ROCKET PHARMACEUTICALS COM Call 18,800 259 n/a n/a n/a
2022-02-14 2021-12-31 13F ROCKET PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F ROCKET PHARMACEUTICALS Cmn Call 19,400 -22.71 580 -47.84 n/a n/a n/a
2021-08-16 2021-06-30 13F ROCKET PHARMACEUTICALS COM Call 25,100 22.44 1,112 22.20 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ROCKET PHARMACEUTICALS COM Call 20,500 -1.44 910 -20.25 n/a n/a n/a
2021-05-17 2021-03-31 13F ROCKET PHARMACEUTICALS COM Call 20,500 910 n/a n/a n/a
2021-02-16 2020-12-31 13F ROCKET PHARMACEUTICALS COM Call 20,800 1,141 n/a n/a n/a
2020-11-16 2020-09-30 13F ROCKET PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F ROCKET PHARMACEUTICALS Cmn Call 10,300 -36.81 216 -4.85 n/a n/a n/a
2020-05-15 2020-03-31 13F ROCKET PHARMACEUTICALS Cmn Call 16,300 5.84 227 -35.33 n/a n/a n/a
2020-02-14 2019-12-31 13F ROCKET PHARMACEUTICALS Cmn Call 15,400 26.23 351 147.18 n/a n/a n/a
2019-11-14 2019-09-30 13F ROCKET PHARMACEUTICALS Cmn Call 12,200 7.96 142 -16.47 n/a n/a n/a
2019-08-14 2019-06-30 13F ROCKET PHARMACEUTICALS Cmn Call 11,300 9.71 170 -6.08 n/a n/a n/a
2019-05-15 2019-03-31 13F ROCKET PHARMACEUTICALS Cmn Call 10,300 -21.37 181 -6.70 n/a n/a n/a
2019-02-14 2018-12-31 13F ROCKET PHARMACEUTICALS Cmn Call 13,100 194 n/a n/a n/a
2017-11-09 2017-09-30 13F INOTEK PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-11 2017-06-30 13F INOTEK PHARMACEUTICALS Cmn Call 21,100 -39.02 40 -42.03 n/a n/a n/a
2017-05-12 2017-03-31 13F INOTEK PHARMACEUTICALS Cmn Call 34,600 88.04 69 -38.39 n/a n/a n/a
2017-02-10 2016-12-31 13F INOTEK PHARMACEUTICALS Cmn Call 18,400 112 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ROCKET PHARMACEUTICALS COM Put 67,300 135.31 241 140.00 n/a n/a n/a
2026-02-17 2025-12-31 13F ROCKET PHARMACEUTICALS COM Put 28,600 -63.66 100 -60.94 n/a n/a n/a
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM Put 78,700 -25.05 257 -0.39 n/a n/a n/a
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM Put 105,000 55.10 257 -43.02 n/a n/a n/a
2025-05-15 2025-03-31 13F ROCKET PHARMACEUTICALS COM Put 67,700 -0.88 452 -47.44 n/a n/a n/a
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM Put 68,300 267.20 859 150.15 n/a n/a n/a
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM Put 18,600 -28.19 344 -38.42 n/a n/a n/a
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM Put 25,900 103.94 558 62.87 n/a n/a n/a
2024-05-15 2024-03-31 13F ROCKET PHARMACEUTICALS COM Put 12,700 -47.30 342 -52.63 n/a n/a n/a
2024-02-14 2023-12-31 13F ROCKET PHARMACEUTICALS COM Put 24,100 19.31 722 74.82 n/a n/a n/a
2023-11-14 2023-09-30 13F ROCKET PHARMACEUTICALS COM Put 20,200 236.67 414 247.06 n/a n/a n/a
2023-08-14 2023-06-30 13F ROCKET PHARMACEUTICALS COM Put 6,000 -43.93 119 -34.97 n/a n/a n/a
2023-05-15 2023-03-31 13F ROCKET PHARMACEUTICALS COM Put 10,700 -40.56 183 -48.01 n/a n/a n/a
2023-02-14 2022-12-31 13F ROCKET PHARMACEUTICALS COM Put 18,000 352 n/a n/a n/a
2022-03-11 2021-09-30 13F/A ROCKET PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F ROCKET PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F ROCKET PHARMACEUTICALS COM Put 71,500 -3.51 3,167 -3.68 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ROCKET PHARMACEUTICALS COM Put 74,100 -0.67 3,288 -19.63 n/a n/a n/a
2021-05-17 2021-03-31 13F ROCKET PHARMACEUTICALS COM Put 74,100 3,288 n/a n/a n/a
2021-02-16 2020-12-31 13F ROCKET PHARMACEUTICALS COM Put 74,600 4,091 n/a n/a n/a
2020-08-14 2020-06-30 13F ROCKET PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F ROCKET PHARMACEUTICALS Cmn Put 19,800 276 n/a n/a n/a
2019-08-14 2019-06-30 13F ROCKET PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F ROCKET PHARMACEUTICALS Cmn Put 13,800 21.05 242 43.20 n/a n/a n/a
2019-02-14 2018-12-31 13F ROCKET PHARMACEUTICALS Cmn Put 11,400 -12.98 169 -47.68 n/a n/a n/a
2018-11-13 2018-09-30 13F ROCKET PHARMACEUTICALS Cmn Put 13,100 323 n/a n/a n/a
2017-11-09 2017-09-30 13F INOTEK PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-11 2017-06-30 13F INOTEK PHARMACEUTICALS Cmn Put 16,700 -26.43 32 -28.89 n/a n/a n/a
2017-05-12 2017-03-31 13F INOTEK PHARMACEUTICALS Cmn Put 22,700 -11.33 45 -71.15 n/a n/a n/a
2017-02-10 2016-12-31 13F INOTEK PHARMACEUTICALS Cmn Put 25,600 156 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.